Product
Sepantronium Bromide
1 clinical trial
11 indications
Indication
High-grade B-cell lymphomaIndication
Burkitt lymphomaIndication
lymphomaIndication
B-cellIndication
Large B-CellIndication
DiffuseIndication
Lymphatic DiseasesIndication
High-GradeIndication
MYC gene rearrangementClinical trial
A Phase 2, Multicenter, Open Label Dose-ranging Study of Sepantronium Bromide in Patients With Relapsed/Refractory c-Myc Rearranged High-grade B-cell Lymphoma (HGBCL)Status: Recruiting, Estimated PCD: 2023-09-01